Packaging Components for Parenteral Drug Development
Datwyler offers the StarterPack packaging system designed to aid in the development of parenteral drug packaging.
Packaging component supplier Datwyler has announced the StarterPack packaging system designed to support parenteral drug development by providing components that offer sealing compatibility to prevent leaks or other seal integrity concerns throughout the manufacturing and handling process.
Developed in collaboration with specialty glass maker Schott, the StarterPack has Datwyler’s OmniFlex stoppers and Prime Caps, along with Schott’s adaptiQ vials.
The OmniFlex stopper is sprayed with a proprietary fluoropolymer designed to provide a barrier between drug and rubber to minimize extractables and leachables.
The Prime Caps, designed for high-speed filling lines, come in two sizes. A center-gated disc is designed to promote enhanced machinability, low bioburden and particulate levels, and container closure integrity.
The StarterPack was introduced to North American market on Aug. 11, 2021, at CPHI North America.
Source: Datwyler
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
